🇺🇸 FDA
Patent

US 11826422

Methods and compositions for adaptive immune modulation

granted A61KA61K2039/544A61K2039/545

Quick answer

US patent 11826422 (Methods and compositions for adaptive immune modulation) held by The Board of Regents of the University of Texas System expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/544, A61K2039/545, A61K2039/55561, A61K31/58